Physician profile
Brandon Bond
NPI 1033552088
$6,510.84
in general payments reported to CMS, 2019-2025
10 companies · $459 in 2025
The $459 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,717 · 2022: $242 · 2023: $92.51 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,078.69 | 2021 | |
| Medtronic, INC. | $2,036.36 | 2021-2025 | Pipeline, Onyx Frontier |
| Stryker Corporation | $1,743.53 | 2021-2025 | Broadway 8, Target, Trevo |
| Depuy Synthes Sales INC. | $370.36 | 2022-2025 | Embotrap |
| Penumbra, INC. | $183.36 | 2021 | |
| Qapel Medical INC | $27.10 | 2023 | |
| Abbott Laboratories | $21.21 | 2021 | |
| Terumo Medical Corporation | $19.67 | 2023 | Angio-Seal |
| Abbvie INC. | $17.49 | 2023 | Botox |
| W. L. Gore & Associates, INC. | $13.07 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.